Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H ( (HK:2252) ) just unveiled an update.
Shanghai MicroPort MedBot (Group) Co., Ltd. has established a Remuneration and Appraisal Committee under its board of directors to enhance corporate governance. This committee is responsible for formulating appraisal standards and reviewing remuneration policies for directors, supervisors, and senior management, which is expected to optimize the company’s management system and accountability.
The most recent analyst rating on (HK:2252) stock is a Sell with a HK$20.00 price target. To see the full list of analyst forecasts on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H stock, see the HK:2252 Stock Forecast page.
More about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
Shanghai MicroPort MedBot (Group) Co., Ltd. operates in the medical technology industry and focuses on developing robotic-assisted surgical systems. The company is incorporated in the People’s Republic of China and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 5,962,532
Technical Sentiment Signal: Buy
Current Market Cap: HK$22.42B
For a thorough assessment of 2252 stock, go to TipRanks’ Stock Analysis page.